Key Financial Inc’s GSK GSK Stock Holding History

Key Financial Inc’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$35.5K	Buy	644 +46	+8%	+$2.49K	0.01%	607
2025 Q4	$29.3K	Hold	598	–	–	0.01%	642
2025 Q3	$27.2K	Buy	598 +38	+7%	+$1.48K	0.01%	645
2025 Q2	$21.5K	Buy	+560	New	+$21.4K	﹤0.01%	677
2022 Q3	–	Sell	-861	Closed	-$47K	–	1140
2022 Q2	$47K	Hold	861	–	–	0.03%	368
2022 Q1	$47K	Hold	861	–	–	0.02%	370
2021 Q4	$47K	Hold	861	–	–	0.02%	356
2021 Q3	$41K	Buy	861 +197	+30%	+$9.89K	0.02%	365
2021 Q2	$33K	Hold	664	–	–	0.02%	401
2021 Q1	$30K	Hold	664	–	–	0.02%	344
2020 Q4	$31K	Buy	+664	New	+$30.5K	0.02%	315
2020 Q2	–	Sell	-753	Closed	-$35K	–	309
2020 Q1	$35K	Buy	+753	New	+$40.2K	0.04%	258

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Key Financial Inc's GSK Position: Q1 2026 in Review

Key Financial Inc increased its GSK (GSK) stake by 7.7% in Q1 2026, buying an estimated $2.49K and bringing the position to 644 shares worth $35.5K. The position accounts for 0.01% of the portfolio, ranked #607.

Key Financial Inc first reported a position in GSK in Q1 2020 and has held it in 12 quarters since. The position peaked at $47K in Q2 2022. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Key Financial Inc held 644 shares of GSK worth $35.5K as of Q1 2026.
Key Financial Inc bought 46 GSK shares in Q1 2026, an estimated $2.49K.
GSK made up 0.01% of Key Financial Inc's portfolio in Q1 2026, its #607 holding.
Key Financial Inc first reported a position in GSK in Q1 2020 and has held it in 12 quarters since.
Key Financial Inc's GSK position peaked at $47K in Q2 2022.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Key Financial Inc's 13F filing for Q1 2026, filed 24 Apr 2026.